Contraception
Volume 81, Issue 1 , Pages 16-21, January 2010

Postmarketing study of ORTHO EVRA® and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism☆

  • Susan S. Jick

      Affiliations

    • Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, 11 Muzzey Street, Lexington, MA 02421, USA
    • Department of Epidemiology, Boston University School of Public Health, Boston, MA 02118, USA
    • Corresponding Author InformationCorresponding author. Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, Lexington, MA 02421, USA. Tel.: +1 781 862 6660; fax: +1 781 862 1680.
    • ,
  • Katrina W. Hagberg

      Affiliations

    • Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, 11 Muzzey Street, Lexington, MA 02421, USA
    • ,
  • Rohini K. Hernandez

      Affiliations

    • Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, 11 Muzzey Street, Lexington, MA 02421, USA
    • Department of Epidemiology, Boston University School of Public Health, Boston, MA 02118, USA
    • ,
  • James A. Kaye

      Affiliations

    • Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, 11 Muzzey Street, Lexington, MA 02421, USA
    • Department of Epidemiology, Boston University School of Public Health, Boston, MA 02118, USA
    • RTI Health Solutions, Waltham, MA 02451-1623, USA

Received 25 June 2009; received in revised form 14 July 2009; accepted 14 July 2009. published online 25 August 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was funded in part by Johnson & Johnson Pharmaceutical Research & Development, LLC.

PII: S0010-7824(09)00349-7

doi:10.1016/j.contraception.2009.07.004

Contraception
Volume 81, Issue 1 , Pages 16-21, January 2010

Article Tools